SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001104659-20-067101
Filing Date
2020-05-28
Accepted
2020-05-28 16:37:15
Documents
14
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A tm2021217-1_10qa.htm   iXBRL 10-Q/A 31674
2 EXHIBIT 31.1 tm2021217d1_ex31-1.htm EX-31.1 4022
3 EXHIBIT 31.2 tm2021217d1_ex31-2.htm EX-31.2 4892
  Complete submission text file 0001104659-20-067101.txt   235475

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA adap-20200331.xsd EX-101.SCH 3195
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE adap-20200331_lab.xml EX-101.LAB 34591
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adap-20200331_pre.xml EX-101.PRE 22716
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2021217-1_10qa_htm.xml XML 4760
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-37368 | Film No.: 20921660
SIC: 2836 Biological Products, (No Diagnostic Substances)